Laura Carot
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Laura Carot has a total of 35 co-authors. Here are the top co-authors by number of shared publications:
- Xavier Bessa
Gastroenterology Department, Hospital del Mar, Barcelona, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain
4 shared publications Cristina Hernández
Epidemiology and Evaluation Department, Hospital del Mar, Barcelona, Spain
3 shared publicationsAgnés Raga
Endoscopy Unit, Department of Digestive Diseases, Hospital del Mar, Barcelona, Spain
2 shared publications- Andrea Buron
Epidemiology and Evaluation Research group,Hospital del Mar Research Institute, Barcelona, Spain; Epidemiology and Evaluation Department, Hospital del Mar, Barcelona, Spain; Research Network on Chronicity, Primary Care and Prevention and Health Promotion (RICAPPS), Madrid, Spain
2 shared publications Cristina Álvarez-Urturi
2 shared publications- Francesc Macià
Department of Epidemiology Hospital del Mar Research Institute Barcelona Spain
2 shared publications
Latest Publications
- Open Access
- 1 December 2018
- Published by Wiley in United European Gastroenterology Journal
- Vol. 6 (10) , 1527-1537
Detection of serrated lesions in proximal colon by simulated sigmoidoscopy vs faecal immunochemical testing in a multicentre, pragmatic, randomised controlled trial
Background: The diagnostic yield of the faecal immunochemical test and sigmoidoscopy in detecting proximal serrated polyps in a colorectal cancer screening programme has not been fully assessed.Aim: We determined the detection rate of proximal serrated polyps by simulated sigmoidoscopy and faecal immunochemical test compared with total colonoscopy in a population‐based, multicentre, nationwide, randomised controlled trial (ColonPrev study).Methods: Sigmoidoscopy yield was simulated based on the UK‐Flexible Sigmoidoscopy Trial for total colonoscopy referral. Definitions were: proximal serrated polyp (proximal serrated polyp): sessile serrated polyp or hyperplastic polyp of any size and proximal at‐risk serrated polyp (at‐risk proximal serrated polyp): sessile serrated polyp of any size or hyperplastic polyp ≥ 10 mm, both located proximally to the splenic flexure.Results: A total of 10,611 individuals underwent faecal immunochemical test and 5059 underwent total colonoscopy and were evaluated by simulated sigmoidoscopy. Sigmoidoscopy and faecal immunochemical test were less accurate in detecting proximal serrated polyps (odds ratio: 0.13; 95% confidence interval: 0.10–0.18 and 0.13; 0.09–0.18, p < 0.0001, respectively). Both tests were inferior to colonoscopy in detecting at‐risk proximal serrated polyps, and sigmoidoscopy was inferior to faecal immunochemical test in detecting these lesions (odds ratio: 0.17; 95% confidence interval: 0.10–0.30 and 0.25; 0.17–0.37, p < 0.0001, respectively).Conclusion: Sigmoidoscopy and faecal immunochemical test are less accurate in detecting proximal serrated polyps than colonoscopy, particularly in women.
- 1 December 2018
- Published by Wiley in United European Gastroenterology Journal
- Vol. 6 (10) , 1527-1537
Open AccessDetection of serrated lesions in proximal colon by simulated sigmoidoscopy vs faecal immunochemical testing in a multicentre, pragmatic, randomised controlled trial
Background: The diagnostic yield of the faecal immunochemical test and sigmoidoscopy in detecting proximal serrated polyps in a colorectal cancer screening programme has not been fully assessed.Aim: We determined the detection rate of proximal serrated polyps by simulated sigmoidoscopy and faecal immunochemical test compared with total colonoscopy in a population‐based, multicentre, nationwide, randomised controlled trial (ColonPrev study).Methods: Sigmoidoscopy yield was simulated based on the UK‐Flexible Sigmoidoscopy Trial for total colonoscopy referral. Definitions were: proximal serrated polyp (proximal serrated polyp): sessile serrated polyp or hyperplastic polyp of any size and proximal at‐risk serrated polyp (at‐risk proximal serrated polyp): sessile serrated polyp of any size or hyperplastic polyp ≥ 10 mm, both located proximally to the splenic flexure.Results: A total of 10,611 individuals underwent faecal immunochemical test and 5059 underwent total colonoscopy and were evaluated by simulated sigmoidoscopy. Sigmoidoscopy and faecal immunochemical test were less accurate in detecting proximal serrated polyps (odds ratio: 0.13; 95% confidence interval: 0.10–0.18 and 0.13; 0.09–0.18, p < 0.0001, respectively). Both tests were inferior to colonoscopy in detecting at‐risk proximal serrated polyps, and sigmoidoscopy was inferior to faecal immunochemical test in detecting these lesions (odds ratio: 0.17; 95% confidence interval: 0.10–0.30 and 0.25; 0.17–0.37, p < 0.0001, respectively).Conclusion: Sigmoidoscopy and faecal immunochemical test are less accurate in detecting proximal serrated polyps than colonoscopy, particularly in women.
- 1 January 2018
- Published by Elsevier in FMC - Formación Médica Continuada en Atención Primaria
- Vol. 25 (1) , 32-37
Cápsula endoscópica en patología digestiva
- 1 January 2018
- Published by Elsevier in FMC - Formación Médica Continuada en Atención Primaria
- Vol. 25 (1) , 32-37
Cápsula endoscópica en patología digestiva
- Open Access
- 4 August 2016
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 48 (11) , 1003-1009
Efficacy of a multifactorial strategy for bowel preparation in diabetic patients undergoing colonoscopy: a randomized trial
Background and study aims: Previous studies have reported that diabetes mellitus is an independent risk factor for inadequate bowel preparation. Current guidelines do not recommend a specific preparation for this patient population. The aims of this study were to assess the efficacy, safety, and tolerability of an adapted preparation protocol for colon cleansing in patients with type 2 diabetes mellitus. Patients and methods: This randomized, single-blind, parallel group, superiority trial compared a conventional bowel preparation protocol (CBP) with a diabetes-specific preparation protocol (DSP). The CBP included a low-fiber diet for 3 days followed by a clear liquid diet for 24 hours before colonoscopy. The DSP included a multifactorial strategy combining an educational intervention, a low-fiber diet, and adjustment of blood glucose-lowering agents. All patients received 4 L of a polyethylene glycol solution in a split-dose regimen. The endoscopists were blinded to the preparation protocol. The primary outcome measure was inadequate bowel preparation according to the Boston Bowel Preparation Scale. Secondary outcome measures included hypoglycemic events, tolerability, and acceptability. Results: A total of 150 patients were included in the study (74 CBP and 76 DSP). Both groups were comparable in terms of baseline characteristics. Inadequate bowel cleansing was more frequent following CBP than DSP (20 % vs. 7 %, P = 0.014; risk ratio 3.1, 95 % confidence interval 1.2 – 8). Only CBP and performance status were independently associated with inadequate bowel preparation. Both preparations were equally tolerated and accepted by patients, and side-effects were similar between the groups. Conclusions: A multifactorial strategy for bowel preparation in patients with diabetes undergoing colonoscopy showed a threefold reduction in the rate of inadequate bowel preparation, with no differences in safety and tolerability compared with conventional preparation. Trial registration: ClinicalTrials.gov (NCT02300779).
- 4 August 2016
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 48 (11) , 1003-1009
Open AccessEfficacy of a multifactorial strategy for bowel preparation in diabetic patients undergoing colonoscopy: a randomized trial
Background and study aims: Previous studies have reported that diabetes mellitus is an independent risk factor for inadequate bowel preparation. Current guidelines do not recommend a specific preparation for this patient population. The aims of this study were to assess the efficacy, safety, and tolerability of an adapted preparation protocol for colon cleansing in patients with type 2 diabetes mellitus. Patients and methods: This randomized, single-blind, parallel group, superiority trial compared a conventional bowel preparation protocol (CBP) with a diabetes-specific preparation protocol (DSP). The CBP included a low-fiber diet for 3 days followed by a clear liquid diet for 24 hours before colonoscopy. The DSP included a multifactorial strategy combining an educational intervention, a low-fiber diet, and adjustment of blood glucose-lowering agents. All patients received 4 L of a polyethylene glycol solution in a split-dose regimen. The endoscopists were blinded to the preparation protocol. The primary outcome measure was inadequate bowel preparation according to the Boston Bowel Preparation Scale. Secondary outcome measures included hypoglycemic events, tolerability, and acceptability. Results: A total of 150 patients were included in the study (74 CBP and 76 DSP). Both groups were comparable in terms of baseline characteristics. Inadequate bowel cleansing was more frequent following CBP than DSP (20 % vs. 7 %, P = 0.014; risk ratio 3.1, 95 % confidence interval 1.2 – 8). Only CBP and performance status were independently associated with inadequate bowel preparation. Both preparations were equally tolerated and accepted by patients, and side-effects were similar between the groups. Conclusions: A multifactorial strategy for bowel preparation in patients with diabetes undergoing colonoscopy showed a threefold reduction in the rate of inadequate bowel preparation, with no differences in safety and tolerability compared with conventional preparation. Trial registration: ClinicalTrials.gov (NCT02300779).
- 1 April 2016
- Published by Elsevier in Gastroenterology
- Vol. 150 (4) , S751
Mo1686 Impact of Additional Colonoscopies in a Population Colorectal Cancer (CRC) Screening Program. Improvement Strategies
- 1 April 2016
- Published by Elsevier in Gastroenterology
- Vol. 150 (4) , S751
Mo1686 Impact of Additional Colonoscopies in a Population Colorectal Cancer (CRC) Screening Program. Improvement Strategies